Search results
Showing 1186 to 1200 of 1364 results for social care
Discontinued Reference number: GID-TA10490
In development Reference number: GID-TA10905 Expected publication date: TBC
AT406 for neoadjuvant treatment of epithelial ovarian cancer [ID1428]
Discontinued Reference number: GID-TA10809
Enasidenib for treating IDH2-positive acute myeloid leukaemia after 2 or more therapies [ID1455]
Discontinued Reference number: GID-TA10356
Ibrutinib combination therapy for untreated diffuse large B-cell lymphoma [ID997]
Discontinued Reference number: GID-TA10382
Discontinued Reference number: GID-TA10422
Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued Reference number: GID-TA10494
Nivolumab with ipilimumab for neoadjuvant treatment of early non-small-cell lung cancer [ID3756]
Discontinued Reference number: GID-TA10631
Rigosertib for previously treated high-risk myelodysplastic syndrome [ID805]
Discontinued Reference number: GID-TA10709
Discontinued Reference number: GID-TA10803
Discontinued Reference number: GID-TA11204
Melanoma (advanced, unresectable, metastatic, NRAS mutation positive) - binimetinib [ID833]
Discontinued Reference number: GID-TA10074
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Discontinued Reference number: GID-TA10375
Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.
Discontinued Reference number: GID-TA10543